Cargando…
Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap–Core Interface of HIV-1 Protease
[Image: see text] Four HIV-1 protease (PR) inhibitors, clinical inhibitors lopinavir and tipranavir, and two investigational compounds 4 and 5, were studied for their effect on the structure and activity of PR with drug-resistant mutation L76V (PR(L76V)). Compound 5 exhibited the best K(i) value of...
Autores principales: | Wong-Sam, Andres, Wang, Yuan-Fang, Zhang, Ying, Ghosh, Arun K., Harrison, Robert W., Weber, Irene T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167001/ https://www.ncbi.nlm.nih.gov/pubmed/30288468 http://dx.doi.org/10.1021/acsomega.8b01683 |
Ejemplares similares
-
Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics
por: Agniswamy, Johnson, et al.
Publicado: (2016) -
Electron microscopy of nanoparticle superlattice formation at a solid-liquid interface in nonpolar liquids
por: Cepeda-Perez, E., et al.
Publicado: (2020) -
The polar and nonpolar interfaces influenced of magnetism in LaMnO(3)-based superlattices
por: Zhou, Guowei, et al.
Publicado: (2023) -
Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes
por: Charpentier, Charlotte, et al.
Publicado: (2013) -
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
por: Wiesmann, Frank, et al.
Publicado: (2011)